ZA200600193B - Use of soluble CD164 in inflammatory and/or autoimmune disorders - Google Patents

Use of soluble CD164 in inflammatory and/or autoimmune disorders

Info

Publication number
ZA200600193B
ZA200600193B ZA200600193A ZA200600193A ZA200600193B ZA 200600193 B ZA200600193 B ZA 200600193B ZA 200600193 A ZA200600193 A ZA 200600193A ZA 200600193 A ZA200600193 A ZA 200600193A ZA 200600193 B ZA200600193 B ZA 200600193B
Authority
ZA
South Africa
Prior art keywords
inflammatory
soluble
autoimmune disorders
autoimmune
disorders
Prior art date
Application number
ZA200600193A
Other languages
English (en)
Inventor
Chvatchko Yolande
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ZA200600193B publication Critical patent/ZA200600193B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA200600193A 2003-07-23 2004-07-23 Use of soluble CD164 in inflammatory and/or autoimmune disorders ZA200600193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03077316 2003-07-23

Publications (1)

Publication Number Publication Date
ZA200600193B true ZA200600193B (en) 2007-04-25

Family

ID=34112463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200600193A ZA200600193B (en) 2003-07-23 2004-07-23 Use of soluble CD164 in inflammatory and/or autoimmune disorders

Country Status (15)

Country Link
US (2) US20060257402A1 (fr)
EP (1) EP1646396A2 (fr)
JP (1) JP4705028B2 (fr)
KR (1) KR20060106810A (fr)
CN (1) CN1845752A (fr)
AR (1) AR045074A1 (fr)
AU (1) AU2004260835A1 (fr)
BR (1) BRPI0412243A (fr)
CA (1) CA2532870A1 (fr)
EA (1) EA009389B1 (fr)
IL (1) IL173197A0 (fr)
NO (1) NO20060781L (fr)
RS (1) RS20060023A (fr)
WO (1) WO2005011728A2 (fr)
ZA (1) ZA200600193B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008527986A (ja) 2005-01-24 2008-07-31 ラボラトワール セローノ ソシエテ アノニム 炎症及び／又は自己免疫疾患における可溶性ｃｄ１６４の使用
NZ578077A (en) 2007-02-12 2012-04-27 Stefan Hansson Diagnosis of preeclampsia using free foetal haemoglobin
ES2571956T3 (es) 2008-07-18 2016-05-27 A1M Pharma Ab Uso médico de la alfa 1-microglobulina antioxidante y eliminadora de radicales
US8392585B1 (en) * 2011-09-26 2013-03-05 Theranos, Inc. Methods and systems for facilitating network connectivity
WO2022099695A1 (fr) * 2020-11-16 2022-05-19 Jiangsu Cell Tech Medical Research Institute Co., Ltd. Fusion cd164 et leurs utilisations
CN114891107A (zh) * 2022-05-12 2022-08-12 北京农学院 一种抗猪cd164l2单克隆抗体制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296792A1 (fr) * 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
EP1409536A2 (fr) * 2001-02-12 2004-04-21 Curagen Corporation Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines

Also Published As

Publication number Publication date
BRPI0412243A (pt) 2006-09-19
EA200600314A1 (ru) 2006-06-30
RS20060023A (en) 2008-06-05
AR045074A1 (es) 2005-10-12
US20090285838A1 (en) 2009-11-19
US8075894B2 (en) 2011-12-13
CN1845752A (zh) 2006-10-11
WO2005011728A3 (fr) 2005-06-02
US20060257402A1 (en) 2006-11-16
EA009389B1 (ru) 2007-12-28
IL173197A0 (en) 2006-06-11
KR20060106810A (ko) 2006-10-12
NO20060781L (no) 2006-03-17
JP2006528159A (ja) 2006-12-14
WO2005011728A2 (fr) 2005-02-10
AU2004260835A1 (en) 2005-02-10
EP1646396A2 (fr) 2006-04-19
CA2532870A1 (fr) 2005-02-10
JP4705028B2 (ja) 2011-06-22

Similar Documents

Publication Publication Date Title
ZA200600387B (en) Hydrolytically-resistant bornon-containing therapeutics and methods of use
HK1208865A1 (en) Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors 6 pde4
IL172986A0 (en) Hairpin -labeled probes and methods of use
GB2420838B (en) Improvements in tubular bodies and methods of forming same
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
EP1608318A4 (fr) Antagonistes cxcr4 et leurs procedes d'utilisation
TWI316092B (en) Alloy and its use
EP1802214A4 (fr) Contenant compact pourvu d'une structure de boitier a contenu pouvant etre inseree et extraite par glissement
AU2003259735A8 (en) Small-mer compositions and methods of use
ZA200600716B (en) Improvements in and to processes
GB0515801D0 (en) Time in databases and applications of databases
EP1735456A4 (fr) Compositions poylmeres et procedes associes d'utilisation
IL182943A0 (en) Ovr110 antibody compositions and methods of use
EP1691661A4 (fr) Molecules de tcr solubles et procedes pour les utiliser
ZA200509700B (en) Caspase inhibitors and uses thereof
IL177709A0 (en) Caspase inhibitors and uses thereof
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1740120A4 (fr) Compositions de naltrexone, à action longue durée et méthode d'utilisation
EP1674498A4 (fr) Copolymere a blocs et utilisation
ZA200605217B (en) Steel desulphurating agent and use thereof in the desulphuration of steel
EP1766092A4 (fr) Compomeres specifiques de cible et techniques d'utilisation
IL173197A0 (en) Cd164 derivatives in inflammatory and autoimmune diseaeses
IL169369A0 (en) Thienopyridazinones and their use in modulation of autoimmune disease
EP1827110A4 (fr) Utilisation d'alisma orientale en cosmetique et compositions en comportant
HRP20140660T1 (en) Compositions and uses therof